Sernova Corp. is a regenerative medicine therapeutics company, focused on developing and commercializing its proprietary implantable prevascularized medical device technologies: the Cell PouchTM and associated technologies including therapeutic cells and local immune protection. The Cell Pouch is a scalable, implantable, medical device, designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells. These cells, following transplantation into the implanted device vascularized environment, release proteins, hormones or other factors into the bloodstream for the long-term treatment of a number of serious, chronic diseases such as diabetes, hemophilia and thyroid disease.